Eli Lilly's approved blood cancer therapy Jaypirca helped delay progression of the disease in previously untreated patients ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

Drugmaker Eli Lilly said on Tuesday it is launching an artificial intelligence and machine learning platform that provides ...

In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...

Lila Biologics, a spinoff from Nobel Laureate David Baker’s research at the University of Washington, is collaborating with ...

Eli Lilly and Company (NYSE: LLY) will participate in the Bernstein's 2nd Annual Healthcare Forum on September 25, 2025.

Big Pharma faces tariff risks, patent cliffs, and regulatory pressure, but innovation and strong pipelines keep Eli Lilly, ...

Takeda names Rhonda Pacheco as U.S. Business Unit President, bringing expertise from Eli Lilly. Read more here.

Drugmaker Eli Lilly said on Tuesday it is launching an artificial intelligence and machine learning platform that provides ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly's new TuneLab platform gives biotech firms AI-powered drug discovery tools using $1 billion of proprietary research ...

Eli Lilly dominates obesity and diabetes treatments with soaring tirzepatide sales and promising oral drug data. Find out why ...